Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5426)
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Soares Karen — Chief Legal Officer
Shares
4,681
Price
$4.61
Total Value
$21.58K
Shares Held After
1,567,741
% of Holdings
0.3%
Vivani Medical, Inc. (VANI)
Williams Gregg — Director
Shares
1,587,301
Price
$1.26
Total Value
$2.00M
Shares Held After
36,119,086
% of Holdings
4.4%
Cytosorbents Corp (CTSO)
MARIANI PETER J — Chief Financial Officer
Shares
100,000
Price
$0.44
Total Value
$44.00K
Shares Held After
638,113
% of Holdings
15.7%
111, Inc. (YI)
Sun Jian David — Director
Shares
58,800
Price
$0.23
Total Value
$13.52K
Shares Held After
413,211
% of Holdings
12.5%
111, Inc. (YI)
Chen Yang Luke — Director
Shares
44,000
Price
$0.23
Total Value
$10.12K
Shares Held After
495,462
% of Holdings
8.2%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
3,666
Price
$3.58
Total Value
$13.12K
Shares Held After
132,715
% of Holdings
2.7%
Alignment Healthcare, Inc. (ALHC)
Maroney Dawn Christine — President
Shares
30,000
Price
$19.55
Total Value
$586.42K
Shares Held After
947,313
% of Holdings
3.1%
ABEONA THERAPEUTICS INC. (ABEO)
Silverstein Christine Berni — Director
Shares
18,160
Price
$5.71
Total Value
$103.70K
Shares Held After
119,562
% of Holdings
13.2%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
600
Price
$69.69
Total Value
$41.81K
Shares Held After
236,384
% of Holdings
0.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
733
Price
$69.69
Total Value
$51.08K
Shares Held After
31,034
% of Holdings
2.3%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
1,899
Price
$24.62
Total Value
$46.75K
Shares Held After
94,462
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Sanders Corazon (Corsee) D. — Director
Shares
2,000
Price
$25.05
Total Value
$50.10K
Shares Held After
21,095
% of Holdings
8.7%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
1,729
Price
$69.69
Total Value
$120.49K
Shares Held After
925,580
% of Holdings
0.2%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
947
Price
$69.69
Total Value
$66.00K
Shares Held After
32,718
% of Holdings
2.8%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
300
Price
$70.62
Total Value
$21.19K
Shares Held After
33,665
% of Holdings
0.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
5,064
Price
$69.42
Total Value
$351.55K
Shares Held After
33,965
% of Holdings
13.0%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
1,636
Price
$68.38
Total Value
$111.88K
Shares Held After
39,029
% of Holdings
4.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
395
Price
$69.69
Total Value
$27.53K
Shares Held After
16,899
% of Holdings
2.3%
Cytosorbents Corp (CTSO)
Chan Phillip P. — Director
Shares
10,333
Price
$0.43
Total Value
$4.44K
Shares Held After
1,744,432
% of Holdings
0.6%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$70.46
Total Value
$528.45K
Shares Held After
385,330
% of Holdings
1.9%
DENTSPLY SIRONA Inc. (XRAY)
Gladden Brian T — Director
Shares
9,985
Price
$10.02
Total Value
$100.00K
Shares Held After
61,849
% of Holdings
16.1%
Jushi Holdings Inc. (JUSH/JUSHF)
MOSIER MICHELLE O — Chief Financial Officer
Shares
1,000
Price
$0.49
Total Value
$486.90
Shares Held After
123,233
% of Holdings
0.8%
Jushi Holdings Inc. (JUSH/JUSHF)
MOSIER MICHELLE O — Chief Financial Officer
Shares
2,500
Price
$0.49
Total Value
$1.22K
Shares Held After
125,733
% of Holdings
2.0%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
1,605
Price
$219.36
Total Value
$352.07K
Shares Held After
2,327,843
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
2,133
Price
$218.17
Total Value
$465.36K
Shares Held After
2,329,448
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
4,276
Price
$217.32
Total Value
$929.28K
Shares Held After
2,331,581
% of Holdings
0.2%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
7,182
Price
$216.51
Total Value
$1.55M
Shares Held After
2,335,857
% of Holdings
0.3%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
3,161
Price
$215.38
Total Value
$680.82K
Shares Held After
2,343,039
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
5,707
Price
$214.35
Total Value
$1.22M
Shares Held After
2,346,200
% of Holdings
0.2%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
5,034
Price
$213.43
Total Value
$1.07M
Shares Held After
2,351,907
% of Holdings
0.2%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
12,142
Price
$212.27
Total Value
$2.58M
Shares Held After
2,356,941
% of Holdings
0.5%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
2,957
Price
$211.61
Total Value
$625.74K
Shares Held After
2,369,083
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
3,267
Price
$210.30
Total Value
$687.05K
Shares Held After
2,372,040
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
2,536
Price
$209.50
Total Value
$531.28K
Shares Held After
2,375,307
% of Holdings
0.1%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
6,250
Price
$35.08
Total Value
$219.22K
Shares Held After
793
% of Holdings
88.7%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
11,322
Price
$0.40
Total Value
$4.53K
Shares Held After
349,907
% of Holdings
3.1%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
159,119
Price
$0.40
Total Value
$63.65K
Shares Held After
4,917,566
% of Holdings
3.1%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
391,019
Price
$8.57
Total Value
$3.35M
Shares Held After
16,622,736
% of Holdings
2.4%
IONIS PHARMACEUTICALS INC (IONS)
Kordasiewicz Holly B. — EVP, Chief Development Officer
Shares
19,842
Price
$74.05
Total Value
$1.47M
Shares Held After
22,458
% of Holdings
46.9%
IONIS PHARMACEUTICALS INC (IONS)
Kordasiewicz Holly B. — EVP, Chief Development Officer
Shares
41,004
Price
$73.09
Total Value
$3.00M
Shares Held After
42,300
% of Holdings
49.2%
Cigna Group (CI)
Kates Jamie G — Chief Accounting Officer
Shares
899
Price
$298.61
Total Value
$268.45K
Shares Held After
2,368
% of Holdings
27.5%
SHOULDER INNOVATIONS, INC. (SI)
Ahearn Matthew Fraser — Director
Shares
15,856
Price
$18.68
Total Value
$296.19K
Shares Held After
273,320
% of Holdings
5.5%
Travere Therapeutics, Inc. (TVTX)
Coughlin Timothy — Director
Shares
10,000
Price
$50.07
Total Value
$500.75K
Shares Held After
56,250
% of Holdings
15.1%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
4,500
Price
$50.00
Total Value
$225.00K
Shares Held After
41,500
% of Holdings
9.8%
Omada Health, Inc. (OMDA)
Shao Wei-Li — President
Shares
4,589
Price
$17.24
Total Value
$79.12K
Shares Held After
316,238
% of Holdings
1.4%
Omada Health, Inc. (OMDA)
Gracey Craig — Chief Accounting Officer
Shares
6,894
Price
$17.42
Total Value
$120.12K
Shares Held After
9,191
% of Holdings
42.9%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
13,095
Price
$72.15
Total Value
$944.86K
Shares Held After
1,065,135
% of Holdings
1.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
97,954
Price
$71.37
Total Value
$6.99M
Shares Held After
1,078,230
% of Holdings
8.3%
Ridgetech Inc. (RDGT)
HRT FINANCIAL LP — 10% Owner
Shares
6,526
Price
$1.51
Total Value
$9.85K
Shares Held After
127,842
% of Holdings
4.9%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
4,252,767
Price
$0.02
Total Value
$68.04K
Shares Held After
2,459,308
% of Holdings
172.9%
Showing 301–350 of 5426 transactions (page 7 of 109)